Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > A Jason Keyes > Profile

A Jason Keyes

Affiliations

  • Director at Actuate Therapeutics Inc. (ACTU), 2025-05-23
  • Chief Financial Officer at Equillium Inc. (EQ), 2025-02-20
  • Director at Sesen Bio Inc. (SESN), 2022-06-24
  • Evp, Chief Financial Officer at Orexigen Therapeutics Inc. (OREX), 2017-10-17
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
EQ $0.65 10,000 $6,500.00 37,720 2025-01-23 Filing
EQ $0.70 10,000 $7,000.00 47,720 2024-11-14 Filing
EQ $0.81 10,000 $8,100.00 57,720 2024-09-26 Filing
EQ $0.87 10,000 $8,700.00 67,720 2024-07-16 Filing
EQ $2.83 7,000 $19,810.00 77,720 2022-08-29 Filing